Fibralign Corporation is a commercial stage healthcare company working in the aena of advanced therapeutic biomedical devices designed to address significant unmet medical needs by utilizing the firm's patented Nanoweave® 3D scaffolding technology. Spun out of Stanford - and currently resident in JLabs San Francisco - Fibralign Corporation has developed a proprietary, computer controlled production process to manufacture 3D oriented matrices based on collagen, laminin, fibrin and other proteins for research and medical applications in cell and tissue engineering. Having received FDA 510(k) clearance for use in soft tissue repair, the company launched its first product, the BioBridge Collagen Matrix. Technologies: Controlled orientation of collagen fibrils in matrices; Multilayer tissue structures; Transparent collagen-based matrices; Precise control of thickness, uniformity, 3D nanostructure; Requires small quantities (1ml minimum) of expensive materials; Semi-automated production process; Easy scale-up to factory process.
